1. A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol. Issue 7 (20th July 2021) Authors: Brown, Emily; Wilton, Moon M; Sprung, Victoria S; Harrold, Joanne A; Halford, Jason C G; Stancak, Andrej; Burgess, Malcolm; Howarth, Elaine; Umpleby, A Margot; Kemp, Graham J; Wilding, John PH; Cuthbertson, Daniel J Journal: BMJ open Issue: Volume 11:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗